Omocianine

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOmocianine
Drug Alias NameomocyanineSF-64
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionTomography enhancers
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFuji PharmaceuticalBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFuji PharmaceuticalBayer AG
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A